Zobrazeno 1 - 10
of 142
pro vyhledávání: '"Jenny He"'
Autor:
Anna Smielewska, Callum Pearson, Ashley Popay, Iain Roddick, Mark Reacher, Edward Emmott, Jenny He, Rachel Thaxter, Carol Chenery, Ian Goodfellow, Amos Burke, Hamid Jalal
Publikováno v:
Wellcome Open Research, Vol 3 (2018)
Background: Human parainfluenza viruses (HPIVs) are significant causes of both upper and lower respiratory tract infections with type 3 (HPIV3) causing the most severe disease in the immunocompromised cohorts. The objective of this study was to analy
Externí odkaz:
https://doaj.org/article/96f57cc1ab84409ba3b0be7a024c59aa
Publikováno v:
Frontiers in Oncology, Vol 7 (2018)
Gliomas are the most common primary malignant brain tumor in humans. Lower grade gliomas are usually less aggressive but many cases eventually progress to a more aggressive secondary glioblastoma (GBM, WHO Grade IV), which has a universally fatal pro
Externí odkaz:
https://doaj.org/article/e8699ad199184f11b61843fcc74867b5
Autor:
Xiang Ma, Desiree A. Johnson, Xinyi Jenny He, Aryanna E. Layden, Shannan P. McClain, Jean C. Yung, Arianna Rizzo, Jordi Bonaventura, Matthew R. Banghart
Publikováno v:
Nature Methods. 20:682-685
Autor:
Shannan P. McClain, Xiang Ma, Desiree A. Johnson, Caroline A. Johnson, Aryanna E. Layden, Jean C. Yung, Susan T. Lubejko, Giulia Livrizzi, X. Jenny He, Jingjing Zhou, Emilya Ventriglia, Arianna Rizzo, Marjorie Levinstein, Juan L. Gomez, Jordi Bonaventura, Michael Michaelides, Matthew R. Banghart
Publikováno v:
bioRxiv
SummaryTraditional methods for site-specific drug delivery in the brain are slow, invasive, and difficult to interface with recordings of neural activity. Here, we demonstrate the feasibility and experimental advantages ofin vivophotopharmacology usi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7821f6b0cc297f894a56989997b38ab
https://europepmc.org/articles/PMC9915677/
https://europepmc.org/articles/PMC9915677/
Autor:
Sreekanth R. Cheruku, Amanda A. Fox, Hooman Heravi, Neelan Doolabh, Jennifer Davis, Jenny He, Christopher Deonarine, Lauren Bereuter, Joan Reisch, Farzin Ahmed, Lisa Skariah, Anthony Machi
Publikováno v:
Seminars in cardiothoracic and vascular anesthesia.
Introduction. Thoracic interfascial plane blocks are increasingly used for pain management after minimally invasive thoracotomy for valve repair and replacement procedures. We hypothesized that the addition of these blocks to the intercostal nerve bl
Autor:
Matthew R. Banghart, Xinyi Jenny He
Publikováno v:
Neuron. 109:1755-1757
Reliable optogenetic tools for sustained, projection-specific presynaptic silencing have been elusive. Recently in Neuron, Mahn et al. (2021) and Copits et al. (2021) describe how the light-activated inhibitory GPCRs eOPN3 and PPO can be used to reve
Autor:
Avi Kenny, Janine van Duijn, One Dintwe, Jack Heptinstall, Randy Burnham, Sheetal Sawant, Lu Zhang, Dieter Mielke, Sharon Khuzwayo, Faatima Laher Omar, Sherry Stanfield-Oakley, Taylor Keyes, Brooke Dunn, Derrick Goodman, Youyi Fong, David Benkeser, Rodger Zou, John Hural, Ollivier Hyrien, Michal Juraska, Alex Luedtke, Lars van der Laan, Elena E. Giorgi, Craig Magaret, Lindsay N. Carpp, Laura Pattacini, Tom van de Kerkhof, Bette Korber, Wouter Willems, Leigh H. Fisher, Hanneke Schuitemaker, Edith Swann, James G. Kublin, Maria G. Pau, Susan Buchbinder, Frank Tomaka, Steven Nijs, Ludo Lavreys, Huub C. Gelderblom, Lawrence Corey, Kathryn Mngadi, Glenda E. Gray, Erica Borducchi, Jenny Hendriks, Kelly E. Seaton, Susan Zolla-Pazner, Dan H. Barouch, Guido Ferrari, Stephen C. De Rosa, M Juliana McElrath, Erica Andersen-Nissen, Daniel J. Stieh, Georgia D. Tomaras, Peter B. Gilbert, Jon Allagappen, Jessica Andriesen, Alison Ayres, Saman Baral, Linda-Gail Bekker, Asiphe Besethi, Caroline Borremans, Esmee Braams, Caroline Brackett, William Brumskine, Roma Chilengi, Rachel Choi, Thozama Dubula, Jaiden Seongmi Dumas, Radhika Etikala, Zelda Euler, Sarah Everett, Nigel Garrett, Huub Gelderblom, Katherine Gill, Kevin Gillespie, Dimitri Goedhart, Erik Goosmann, Shannon Grant, Ellie Hands, Barton Haynes, Bronwill Herringer, Zaheer Hoosain, Mina Hosseinipour, Portia Hunidzarira, Julia Hutter, Mubiana Inambao, Craig Innes, William Kilembe, Philippus Kotze, Sheena Kotze, Fatima Laher, Imre Laszlo, Erica Lazarus, Hua-Xin Liao, Yong Lin, Helen Lu, Judith Lucas, Mookho Malahleha, Tara McNair, Peter Meerts, Zinhle Mgaga, Mahlodi Montlha, Boitumelo Mosito, Andrew Moultrie, Sarah Mudrak, Valérie Oriol-Mathieu, Marcella Sarzotti-Kelsoe, Matson Tso Mathebula, Mitch Matoga, Rachael McClennen, Pamela Mda, Vimla Naicker, Logashvari Naidoo, Cindy-Ann Okkers, Saleha Omarjee, Hella Pasmans, Tricia Philip, Abraham Pinter, Annah Pitsi, Ornelia Ramos, April Randhawa, Sanne Roels, Shamiska Rohith, Lucy Rutten, Jerald Sadoff, Gabriela Salinas, Yvonne Salzgeber, Lorenz Scheppler, Katharine Schwedhelm, Nicolette Schuller, Angelina Sharak, Carrie Sopher, Terence Tafatatha, Simbarashe G. Takuva, Chan Tang, An Vandebosch, Edna Viegas, Valentin Voillet, Frank Wegmann, Mo Weijtens, Stephany Wilcox, Anthony Williams, Chenchen Yu, Pei-Chun Yu, Olive Yuan, Xuehan Zhang
Publikováno v:
EBioMedicine, Vol 108, Iss , Pp 105320- (2024)
Summary: Background: The HVTN 705 Imbokodo trial of 2636 people without HIV and assigned female sex at birth, conducted in southern Africa, evaluated a heterologous HIV-1 vaccine regimen: mosaic adenovirus 26-based vaccine (Ad26.Mos4.HIV) at Months 0
Externí odkaz:
https://doaj.org/article/f41b2bdf77344ddab5c165f46025f8a4
Autor:
Fiona Collinson, Kara-Louise Royle, Jayne Swain, Christy Ralph, Anthony Maraveyas, Tim Eisen, Paul Nathan, Robert Jones, David Meads, Tze Min Wah, Adam Martin, Janine Bestall, Christian Kelly-Morland, Christopher Linsley, Jamie Oughton, Kevin Chan, Elisavet Theodoulou, Gustavo Arias-Pinilla, Amy Kwan, Luis Daverede, Catherine Handforth, Sebastian Trainor, Abdulazeez Salawu, Christopher McCabe, Vicky Goh, David Buckley, Jenny Hewison, Walter Gregory, Peter Selby, Julia Brown, Janet Brown
Publikováno v:
Health Technology Assessment, Vol 28, Iss 45 (2024)
Background There is interest in using treatment breaks in oncology, to reduce toxicity without compromising efficacy. Trial design A Phase II/III multicentre, open-label, parallel-group, randomised controlled non-inferiority trial assessing treatment
Externí odkaz:
https://doaj.org/article/f262d31cdee84d25b7afd7439e0362e7
Autor:
Xinyi Jenny He, Xiang Ma, Brenda L. Bloodgood, Matthew R. Banghart, Connor E. Weiss, Janki Patel
Publikováno v:
eLife, Vol 10 (2021)
eLife
eLife
Functional interactions between G protein-coupled receptors are poised to enhance neuronal sensitivity to neuromodulators and therapeutic drugs. Mu and delta opioid receptors (MORs and DORs) can interact when overexpressed in the same cells, but whet